Gennex Laboratories [GENNEX] vs Gujarat Themis [GUJTHEM] Detailed Stock Comparison

Gennex Laboratories

Gujarat Themis
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Gennex Laboratories wins in 6 metrics, Gujarat Themis wins in 13 metrics, with 0 ties. Gujarat Themis appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Gennex Laboratories | Gujarat Themis | Better |
---|---|---|---|
P/E Ratio (TTM) | 16.41 | 103.15 | Gennex Laboratories |
Price-to-Book Ratio | 1.18 | 18.55 | Gennex Laboratories |
Debt-to-Equity Ratio | 13.93 | 12.27 | Gujarat Themis |
PEG Ratio | 2.80 | -3.26 | Gujarat Themis |
EV/EBITDA | 15.81 | 71.94 | Gennex Laboratories |
Profit Margin (TTM) | 11.46% | 30.17% | Gujarat Themis |
Operating Margin (TTM) | 13.37% | 33.14% | Gujarat Themis |
EBITDA Margin (TTM) | 13.37% | 33.14% | Gujarat Themis |
Return on Equity | 9.31% | 19.64% | Gujarat Themis |
Return on Assets (TTM) | 7.08% | 16.19% | Gujarat Themis |
Free Cash Flow (TTM) | $-197.44M | $-251.22M | Gennex Laboratories |
Dividend Yield | N/A | 0.17% | N/A |
1-Year Return | -41.07% | 93.18% | Gujarat Themis |
Price-to-Sales Ratio (TTM) | 2.16 | 31.17 | Gennex Laboratories |
Enterprise Value | $2.75B | $46.35B | Gujarat Themis |
EV/Revenue Ratio | 1.92 | 31.35 | Gennex Laboratories |
Gross Profit Margin (TTM) | 35.05% | 77.71% | Gujarat Themis |
Revenue per Share (TTM) | $7 | $14 | Gujarat Themis |
Earnings per Share (Diluted) | $0.78 | $4.10 | Gujarat Themis |
Beta (Stock Volatility) | 0.31 | -0.37 | Gujarat Themis |
Gennex Laboratories vs Gujarat Themis Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Gennex Laboratories | -0.55% | 8.38% | 11.50% | 2.32% | -9.28% | -25.32% |
Gujarat Themis | 1.29% | 5.76% | 7.50% | 23.75% | 49.86% | 73.70% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Gennex Laboratories | -41.07% | 96.92% | 228.21% | 181.32% | 759.06% | 975.63% |
Gujarat Themis | 93.18% | 93.18% | 93.18% | 93.18% | 93.18% | 93.18% |
News Based Sentiment: Gennex Laboratories vs Gujarat Themis
Gennex Laboratories
News based Sentiment: MIXED
Gennex Laboratories experienced a stock price reversal and reported positive Q1 FY2026 results, but continues to face significant long-term declines and saw a large insider sell transaction. These mixed signals create a complex investment picture, making October a noteworthy but not transformative month for the company.
Gujarat Themis
News based Sentiment: MIXED
October 2025 was a mixed month for Gujarat Themis Biosyn Ltd., with declining financial results countered by positive stock movement and investor sentiment. While the revenue and profit decreases are concerning, the market's reaction and analyst targets suggest potential for recovery, making it a cautiously optimistic outlook.
Performance & Financial Health Analysis: Gennex Laboratories vs Gujarat Themis
Metric | GENNEX | GUJTHEM |
---|---|---|
Market Information | ||
Market Cap | ₹3.11B | ₹46.19B |
Market Cap Category | Small cap | Small cap |
10 Day Avg. Volume | 642,874 | 353,996 |
90 Day Avg. Volume | 571,621 | 202,276 |
Last Close | ₹12.73 | ₹428.35 |
52 Week Range | ₹10.84 - ₹19.00 | ₹208.00 - ₹434.00 |
% from 52W High | -33.00% | -1.30% |
All-Time High | ₹29.00 (Sep 16, 2024) | ₹434.00 (Oct 06, 2025) |
% from All-Time High | -56.10% | -1.30% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.21% | -0.08% |
Quarterly Earnings Growth | 0.08% | -0.32% |
Financial Health | ||
Profit Margin (TTM) | 0.11% | 0.30% |
Operating Margin (TTM) | 0.13% | 0.33% |
Return on Equity (TTM) | 0.09% | 0.20% |
Debt to Equity (MRQ) | 13.93 | 12.27 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹10.85 | ₹22.80 |
Cash per Share (MRQ) | ₹2.40 | ₹1.15 |
Operating Cash Flow (TTM) | ₹-75,467,000 | ₹970.68M |
Levered Free Cash Flow (TTM) | ₹181.23M | ₹487.72M |
Dividends | ||
Last 12-Month Dividend Yield | N/A | 0.17% |
Last 12-Month Dividend | ₹0.00 | ₹0.67 |
Valuation & Enterprise Metrics Analysis: Gennex Laboratories vs Gujarat Themis
Metric | GENNEX | GUJTHEM |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 16.41 | 103.15 |
Forward P/E | N/A | N/A |
PEG Ratio | 2.80 | -3.26 |
Price to Sales (TTM) | 2.16 | 31.17 |
Price to Book (MRQ) | 1.18 | 18.55 |
Market Capitalization | ||
Market Capitalization | ₹3.11B | ₹46.19B |
Enterprise Value | ₹2.75B | ₹46.35B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 1.92 | 31.35 |
Enterprise to EBITDA | 15.81 | 71.94 |
Risk & Other Metrics | ||
Beta | 0.31 | -0.37 |
Book Value per Share (MRQ) | ₹10.85 | ₹22.80 |
Financial Statements Comparison: Gennex Laboratories vs Gujarat Themis
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | GENNEX | GUJTHEM |
---|---|---|
Revenue/Sales | ₹341.78M | ₹358.73M |
Cost of Goods Sold | ₹221.97M | ₹79.97M |
Gross Profit | ₹119.81M | ₹278.76M |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹45.68M | ₹118.87M |
EBITDA | ₹73.49M | ₹141.96M |
Pre-Tax Income | ₹58.66M | ₹121.20M |
Income Tax | ₹8.50M | ₹30.58M |
Net Income (Profit) | ₹50.16M | ₹90.62M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | GENNEX | GUJTHEM |
---|---|---|
Cash & Equivalents | ₹545.89M | ₹116.94M |
Total Current Assets | ₹1.81B | ₹519.73M |
Total Current Liabilities | ₹445.55M | ₹205.60M |
Long-Term Debt | ₹168.93M | ₹296.36M |
Total Shareholders Equity | ₹1.95B | ₹2.48B |
Retained Earnings | ₹562.59M | ₹2.37B |
Property, Plant & Equipment | ₹88.69M | ₹411.30M |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | GENNEX | GUJTHEM |
---|---|---|
Operating Cash Flow | N/A | N/A |
Capital Expenditures | N/A | N/A |
Free Cash Flow | N/A | N/A |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | GENNEX | GUJTHEM |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 642,874 | 353,996 |
Average Daily Volume (90 Day) | 571,621 | 202,276 |
Shares Outstanding | 227.45M | 108.97M |
Float Shares | 132.11M | 30.70M |
% Held by Insiders | 0.31% | 0.71% |
% Held by Institutions | 0.00% | 0.01% |
Dividend Analysis & Yield Comparison: Gennex Laboratories vs Gujarat Themis
Metric | GENNEX | GUJTHEM |
---|---|---|
Last 12-Month Dividend | ₹0.00 | ₹0.67 |
Last 12-Month Dividend Yield | N/A | 0.17% |
3-Year Avg Annual Dividend | ₹0.00 | ₹0.22 |
3-Year Avg Dividend Yield | N/A | 0.17% |
3-Year Total Dividends | ₹0.00 | ₹0.67 |
Ex-Dividend Date | N/A | Sep 04, 2025 |